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Nephrotic syndrome (NS) is one of the most commonly encountered 
kidney diseases in childhood and one of the kidney diseases most 
frequently referred to a specialised centre for management by a 
paediatric nephrologist or a paediatrician with a special interest in 
childhood kidney diseases. The disease is characterised by heavy 
proteinuria (≥3+) on urinary dipstick analysis, or a random spot 
urine protein/creatinine ratio ≥200 mg/mmol, or a 24-hour urine 
protein excretion >40 mg/m2/h, hypoalbuminaemia ≤25 g/L and 
oedema. The estimated worldwide incidence of NS is 4.7 per 100 000 child -
ren (range 1.15 - 16.9).[1]
It has been documented that there is a strong geographical 
variation in the pattern of the disease and that certain ethnic groups, 
specifically South Asians and Africans, have a higher incidence.[2] 
Several studies from South Africa (SA) have documented strong racial 
differences with regard to response to treatment, histopathological 
subtypes and outcome.[3-13] 
In the previous millennium, from the late 1970s onwards, the 
spectrum of the disease documented in the four major racial groups 
in SA, i.e. African, Indian, white and mixed race (decedents from 
blacks, whites and slaves from West and East Africa and from the 
Far East),[14] showed distinct differences. While the pattern of the 
disease in Indians, whites and persons of mixed race was shown to 
be similar to that described in industrialised countries, black African 
children showed distinct differences.[3-6] The latter often had secondary 
identifiable causative agents, with a high prevalence of steroid-resistant 
(SR) disease, irrespective of the histopathological pattern.[3-5] The high 
prevalence of infections, lower socioeconomic status, environmental 
factors, inequality of access to healthcare services and genetic factors 
were postulated as possible reasons for these differences.
In this study, we report on the histopathological spectrum, 
response to steroids and outcome in children seen in the new 
millennium at a central hospital in KwaZulu-Natal Province, SA, and 
highlight differences in the pattern of disease in black African and 
Indian children.
Methods
This was a retrospective study in children (1 - 14 years old) referred 
to Inkosi Albert Luthuli Central Hospital (IALCH) in KwaZulu-
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Background. The outcome and response of idiopathic nephrotic syndrome (NS) to steroids have been linked to race.
Objectives. To determine the age of presentation, sex, race, histopathology, kidney function and disease status at the last hospital visit and 
correlate these with steroid response in Indian and black African children with idiopathic NS.
Methods. This is a retrospective review of 231 children aged 1 - 14 years, who were seen at Inkosi Albert Luthuli Central Hospital, Durban, 
South Africa (SA) from 2003 to 2018.
Results. The mean (standard deviation (SD)) age of presentation was 6.2 (3.4) years, with the majority of children (n=107; 46.3%) presenting 
at an early age (1 - 3 years) with a mean (SD) follow-up of 3.0 (2.4) years. One-hundred and twenty-one (52.4%) were males and 110 (47.6%) 
were females, with a male/female ratio of 1.1:1. There were 166 (71.9%) black African and 65 (28.1%) Indian children. The latter presented 
at a younger age than black African children (p<0.001). Seventy-six (32.9%) children were steroid sensitive (SS) and 155 (67.1%) were steroid 
resistant (SR). Black African children were more likely to be SR (odds ratio (OR) 2.0; p=0.02; 95% confidence interval (CI) 1.1 - 3.7). A 
kidney biopsy was performed in 209 (90.5%) children. Minimal change disease (MCD) was observed in 32 (13.9%) children and 162 (70.1%) 
had focal segmental glomerulosclerosis (FSGS). Black African children were slightly more likely to have FSGS; this, however, did not reach 
statistical significance (122/166 (73.5%) v. 40/65 (61.5%); OR 1.73; p=0.08; 95% CI 0.94 - 3.18). On comparing disease status at last hospital 
visit by race, 49/65 (75.4%) Indian and 94/166 (56.6%) black African children were in remission. At last hospital visit, black African children 
were less likely to be in remission than Indian children (OR 0.47; p=0.02; 95% CI 0.2 - 0.9), while 15/65 (23.1%) Indian and 47/166 (28.3%) 
black African children had relapsed, with no significant difference between the two groups. One (1.5%) Indian child and 25 (15.1%) black 
African children had end-stage kidney disease (ESKD) (OR 9.27; p=0.03; 95% CI 1.2 - 70.4) ‒ the majority had FSGS. Sixteen (61.5%) 
received renal replacement therapy.
Conclusions. Our study shows a rising incidence of FSGS, with the majority of patients having SRNS, particularly black African children. 
This highlights the need for alternative efficacious therapy in the management of this disease. Also, a higher percentage of black African 
children with both MCD and FSGS were SS on histopathological examination, which was in keeping with reports from other regions in SA. 
There are still major challenges for the inclusion of all children into a chronic dialysis and transplant programme. 
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Natal from 2003 to 2018. IALCH is the 
central, tertiary/quaternary referral hospital 
for KwaZulu-Natal and its neighbouring 
provinces for children with complex and 
chronic kidney disorders. 
Using the Meditech database, 420 child-
ren were identified as having NS, based 
on the International Classification of 
Diseases 10th Revi sion (ICD10) coding. 
One hundred and eighty-nine children were 
excluded; 99 were diagnosed with secondary 
NS (15 with the nephrotic phase of acute post-
streptococcal glomerulonephritis, 62 with 
HIV nephropathy, 4 with IgA nephropathy, 
6 with hepatitis B-associated nephropathy, 4 
with systemic lupus erythematosus nephritis 
and 8 with crescentic glomerulonephritis 
of unknown aetiology); 38 children had 
congenital NS; 13 had infantile NS; records 
were incomplete for 7; and 1 patient refused 
a kidney biopsy. Twenty-seven children who 
had visited the hospital only once were 
excluded from the study, as their steroid 
response could not be accurately determined. 
Only 2 children of mixed race and 2 white 
children were seen at IALCH during the 
study period; they were also excluded from 
the analysis (Fig. 1).
Children with primary NS (n=231) 
comprised the study group. The following data 
were extracted from the hospital computer 
records: patient demographics, age at first 
hospital visit, age at diagnosis, clinical findings 
(including presenting symptoms, weight, 
height, blood pressure, urine dipstick analysis 
and any other significant clinical findings), 
laboratory data at first and last hospital visit, 
estimated glomerular filtration rate, kidney 
biopsy histopathological findings, response 
to steroids, use of immunosuppressive 
therapy other than steroids, disease status at 
last hospital visit, mode of dialysis therapy 
and kidney transplant (in children with end-
stage kidney disease (ESKD). The children’s 
areas of residence were classified as urban or 
rural according to the Statistics South Africa 
Census 2011 criteria.[15]
Investigations
The following investigations were per-
formed to exclude secondary causes of NS: 
antistreptolysin O titre, hepatitis B screen 
for s- and e-antigens and antibodies, hepa-
titis A IgM, hepatitis C total antibody, 
cytomegalovirus IgM (if positive, a viral 
load was done), Epstein-Barr virus IgM, 
parvovirus B19 IgM, HIV IgG, rapid plasma 
reagin test for syphilis, antinuclear factor 
and serum complement (C3 and C4). A renal 
biopsy was performed in 209 children who 
frequently relapsed, and who were steroid 
dependant or SR. After 2 years a repeat 
kidney biopsy was done in children treated 
with calcineurin inhibitors (CNIs) to assess 
for CNI toxicity and disease progression. 
Kidney biopsies were examined by light 
microscopy, immunohistochemistry and 
electron microscopy in the Department of 
Anatomical Pathology of the National Health 
Laboratory Service at IALCH. In 22 child -
ren a kidney biopsy was not performed, 
as they had a clinical course suggestive 
of steroid-sensitive (SS) minimal change 
disease (MCD) NS and were classified as 
presumed MCD.
Blood pressure was measured using an 
appropriate-sized cuff, with the child at rest 
and seated upright. Systolic and diastolic 
blood pressures were measured using 
the oscillometric method, employing an 
automated blood pressure monitor Edan 
Model 3 (Edan, USA). Hypertension (HPT) 
was defined by the Fourth Report on the 
Diagnosis, Evaluation, and Treatment 
of High Blood Pressure in Children and 
Adolescents[16] as follows: normal <90th per-
centile; prehypertension ≥90th - <95th per-
centile or >120/80 mmHg in adolescents; 
stage 1 HPT if between ≥95th and 99th per -
centile plus 5 mmHg; and stage 2 HPT 
>99th percentile plus 5 mmHg. Glomerular 
filtration rate was estimated (eGFR) using 
the modified Schwartz formula,[17] and 
children were classified according to the 
Kidney Disease Outcomes Quality Initiative 
(KDIGO) guidelines for chronic kidney 
disease (CKD).[18] Daily oral prednisone at 
a dose of 2 mg/kg/day (maximum 60 mg) 
was administered as initial treatment and 
steroid response was assessed after 6 weeks. 
Children who frequently relapsed and were 
steroid dependant or SR were treated with 
additional immunosuppressants, including 
cyclophosphamide, CNIs (cyclosporin or 
tacrolimus) or mycophenolate mofetil.
Disease status at last hospital visit was 
categorised as follows:
Steroid-sensitive nephrotic syndrome 
(SSNS): Children whose proteinuria resolved 
for 3 consecutive days after 6 weeks of daily 
steroid therapy.
Reason for exclusion, n=189
   Secondary nephrotic syndrome, n=99
   Congenital nephrotic syndrome, n=38
   Infantile nephrotic syndrome, n=13
   Incomplete records, n=7
   Refused biopsy, n=1
   Children who visited hospital once, n=27
   White children, n=2
   Mixed-race children, n=2
Nephrotic syndrome, N=420
(January 2003 - December 2018)
Steroid sensitive, 
n=76 (32.9%)
FSGS, n=9 (50.0%)
MCD, n=2 (11.15)
Not biopsied
Presumed MCD, 
n=7 (38.9%)
Study population, n=231
Steroid resistant, 
n=155 (67.1%)
FSGD, n=138 (89.0%)
MCD, n=9 (5.8%)
MGN, n=7 (4.5%)
MPGN, n=1 (0.6%)
Steroid sensitive, 
n=47 (61.8%)
Frequent relapser, 
n=11 (14.5%)
Steroid dependent,
n=18 (23.7%)
FSGS, n=10 (21.3%)
MCD, n=15 (31.9%)
MGN, n=3 (6.4%)
MPGN, n=2 (4.3%)
MesProlGN, n=2 (4.3%)
FSGS, n=5 (45.5%)
MCD, n=6 (54.5%)
Not biopsied
Presumed MCD, 
n=15 (31.9%)
Fig. 1. Flow chart of the study. (FSGS = focal segmental glomerulosclerosis; MCD = minimal change 
disease; MGN = membranous glomerulonephritis; MPGN = membranoproliferative glomerulonephritis; 
MesProlGN = mesangioproliferative glomerulonephritis.)
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Steroid-dependent nephrotic syndrome (SDNS): Children who 
relapsed twice consecutively while on steroid therapy or within 2 weeks 
of steroid discontinuation.
Frequent-relapse nephrotic syndrome: Children who relapsed ≥2 times 
within 6 months of an initial response to steroids or ≥4 times in any 
12-month period. 
Steroid-resistant nephrotic syndrome (SRNS): Children with protein -
uria persisting after 6 weeks of steroid therapy. 
Remission: The absence of oedema and proteinuria on urinary 
dipstick analysis (protein = 0/trace) on 3 consecutive early-morning 
urine specimens, or alternately a random urine protein/creatinine 
ratio <0.05 g/mmol. 
Relapse: The presence of oedema and proteinuria on urinary 
dipstick analysis (protein ≥2+) or protein/creatinine ratio >0.05 g/mmol 
for 3 consecutive days after a period of remission. 
Renal function: This was assessed by an eGFR using the modified 
bedside Schwartz formula,[17] and classified according to the KDIGO 
guidelines for CKD.[18]
Data were captured on Excel version 16 (Microsoft, USA) and all 
children identifiers were removed. Data were imported into SPSS 
version 24 (IBM Corp., USA) for analysis. A descriptive analysis 
of the data included means, standard deviations (SDs), ranges, 
frequency distribution tables and proportions. A p-value <0.05 was 
considered statistically significant.
Ethical approval
Permission to perform the study was granted by the institutional 
hospital medical manager, and ethical approval was obtained from 
the Biomedical Research Ethics Committee of the University of 
KwaZulu-Natal (ref. no. BE435/16). 
Results
Overall findings 
A total of 231 children with primary NS treated over 16 years at 
IALCH were included in the study; 121 (52.4%) were males and 110 
(47.6%) were females, with a male/female ratio of 1.1:1. There were 
166 (71.9%) black African and 65 (28.1%) Indian children. Most 
children were diagnosed at an early age: 107 (46.3%) between 1 and 
3 years, 69 (29.9%) between 4 and 7 years and 55 (23.8%) between 
8 and 12 years (p<0.001), the mean (SD) age of presentation being 
4.8 (3.3) years. The majority of children (n=183; 79.2%) were from 
an urban setting while 48 (20.8%) were from a rural setting. One 
hundred and six (45.9%) children were asymptomatic on initial 
presentation and 125 (54.1%) had varying degrees of oedema as 
their presenting symptom. Blood pressure assessment at first visit 
showed that 89 (38.5%) children were normotensive, 25 (10.8%) 
prehypertensive, 73 (31.6%) had stage 1 HPT and 44 (19.0%) stage 
2 HPT. 
Indian children presented at a younger age: 47/65 (72.3%) between 
1 and 3 years compared with 60/166 (36.1%) black African children 
(p<0.001). Most black African children presented at an older age: 
11/65 (16.9%) Indian v. 58/166 (34.9%) black African children 
presented between 4 and 7 years (p=0.01) and 7/65 (10.8%) Indian 
v. 48/166 (28.9%) black African children presented between 8 and 14 
years (p=0.004). There was a significantly larger proportion of Indian 
males v. females (42 (64.6%) v. 23 (35.4%), respectively; p=0.02), 
whereas in black African children there was a significantly larger 
proportion of females v. males (87 (52.4%) v. 79 (47.6%), respectively; 
p=0.02). Sixty-five (100%) Indian children v. 118 (71.1%) black 
African children were from an urban setting, with all children from a 
rural setting being black African (p<0.001). There were no significant 
differences in body mass index or presence of oedema on initial 
presentation between the racial groups. On initial presentation, black 
African children were more than twice as likely to have stage 2 HPT 
than Indian children (37/66 (22.3%) black African v. 7/65 (10.8%) 
Indian; odds ratio (OR) 2.38; p=0.05; 95% confidence interval (CI) 
1.0 - 5.6) (Table 1).
At last hospital visit, 76 (32.9%) children were SS (47/231 (20.3%) 
had infrequent relapses, 11/231 (4.8%) had frequent relapses, 18/231 
(7.8%) were steroid dependent) and 155 (67.1%) were SR. A total of 
29/65 (44.6%) children with SSNS were Indian and 47/166 (28.3%) 
were black African. Comparing children with SRNS, 36/65 (55.4%) 
were Indian and 119/166 (71.7%) were black African. The latter were 
more likely to be SR (OR 2.0; p=0.02; 95% CI 1.1 - 3.7).
The histopathological findings of kidney biopsies in 209 (90.5%) child -
ren who frequently relapsed, who were steroid dependent or SR are 
Table 1. Demographics and clinical characteristics of children with primary nephrotic syndrome
Demographics Indian (n=65), n (%)* Black (n=166), n (%)* p-value OR 95% CI
Age at diagnosis, years
1 - 3 47 (72.3) 60 (36.1) <0.001 0.22 0.1 - 0.4
4 - 7 11 (16.9) 58 (34.9) 0.01 2.64 1.3 - 5.4
8 - 14 7 (10.8) 48 (28.9) 0.004 3.37 1.4 - 7.9
Residence
Urban 65 (100.0) 118 (71.1) <0.001 - -
Rural 0 (0.0) 48 (28.9) - -
Sex
Female 23 (35.4) 87 (52.4) 0.02  - -
Male 42 (64.6) 79 (47.6)  - -
Blood pressure
Normal 31 (47.7) 58 (34.9) NS  - -
Prehypertension 5 (7.7) 20 (12.0) NS  - - 
Stage 1 22 (33.8) 51 (30.7) NS  - - 
Stage 2 7 (10.8) 37 (22.3) 0.05 2.38 1.0 - 5.6
BMI, median (IQR) 17.5 (16 - 20) 17.7 (16 - 19) NS - -
OR = odds ratio; CI = confidence interval; NS = not significant; BMI = body mass index; IQR = interquartile range. 
*Unless otherwise indicated.
681       July 2020, Vol. 110, No. 7
RESEARCH
shown in Fig. 2. There were no significant 
differences between the two racial groups 
in the occurence of MCD. One hundred 
and sixty-two (70.1%) children had focal 
segmental glomerulosclerosis (FSGS): 
40/65 (61.5%) were Indian and 122/166 
(73.5%) black African. Although the latter 
were slightly more likely to have FSGS, this 
did not reach statistical significance (OR 
1.73; p=0.08; 95% CI 0.94 - 3.18). Fifteen 
(6.5%) black African children had other 
histopathological findings: 3/15 (20.0%) 
membranoproliferative glomerulonephritis, 
10/15 (66.7%) idiopathic membranous 
glomerulonephritis and 2/15 (13.4%) 
mesangioproliferative glomerulonephritis 
(Table 2). 
The mean (SD) follow-up of all children 
was 3.0 (2.4) years; Indian children were 
followed up for a mean (SD) of 3.5 (2.8) years 
and black African children for a mean (SD) 
of 2.8 (2.2) years. At last hospital visit, 
143 (61.9%) children were in remission, 
62 (26.8%) had relapsed and 26 (11.3%) 
had ESKD. Six of the 26 children with 
ESKD received peritoneal dialysis only, 2 
received haemodialysis only, and 8 received 
haemodialysis and peritoneal dialysis. Four 
children received a live-related kidney 
donor transplant; 3 were females and all had 
SR FSGS. Ten of 26 (38.5%) children who 
did not receive renal replacement therapy 
included those who did not qualify for the 
programme; they were therefore referred to 
their base hospitals for palliative follow-up 
care. On comparing disease status at last 
hospital visit by race, 49/65 (75.4%) Indian 
and 94/166 (56.6%) black African children 
were in remission. Black African children 
were less likely to be in remission than Indian 
children (OR 0.47; p=0.02; 95% CI 0.2 - 0.9). 
On comparing Indian and black African 
children who were in relapse at last hospital 
visit, there was no significant difference 
between the two groups. One (1.5%) Indian 
child and 25 (15.1%) black African children 
had ESKD at last hospital visit. Therefore, 
black African children were more likely to 
have ESKD than Indian children (OR 9.27; 
p=0.03; 95% CI 1.2 - 70.4) (Table 2).
When stratified by kidney histopathology, 
at last hospital visit 28/32 (87.5%) children 
with MCD were in remission, 4 (12.5%) had 
relapsed, and none had progressed to ESKD. 
Of the children who infrequently relapsed, 
who did not undergo a kidney biopsy and 
were presumed to have MCD, 19/22 (86.4%) 
were in remission, 2/22 (9.1%) had relapsed 
and 1 (4.5%) was lost to follow-up and 
presented with ESKD. In children with FSGS 
on histopathology, 85/162 (52.5%) were in 
remission, 53/162 (32.7%) had relapsed and 
Table 2. Histopathological findings and disease status at last hospital visit in Indian and black African children with primary 
nephrotic syndrome*
Histopathology
Steroid sensitive
Indian (n=29), n (%) Black (n=47), n (%) Total (n=76), n (%) p-value OR 95% CI
Final biopsy assessment
FSGS 9 (31.0) 15 (31.9) 24 (31.6) NS  - -
MCD 6 (20.7) 17 (36.2) 23 (30.3) NS - -
Other† 0 (0.0) 7 (14.9) 7 (9.2) NS - -
Disease status at last hospital visit
Remission 24 (82.8) 44 (93.6) 68 (89.0) NS - -
Relapse 5 (17.2) 2 (4.3) 7 (9.0) 0.08 0.21 0.04 - 1.18
ESKD 0 (0.0) 1 (2.1) 1 (1.0) NS - -
Steroid resistant
Indian (n=36), n (%) Black (n=119), n (%) Total (n=155 ), n (%) p-value OR 95% CI
Final biopsy assessment
FSGS 31 (86.1) 107 (89.9) 138 (89.0) NS - -
MCD 5 (13.9) 4 (3.4) 9 (5.8) 0.03 0.22 0.05 - 0.85
Other† 0 (0.0) 8 (6.7) 8 (5.2) NS -  -
Disease status at last hospital visit
Remission 25 (69.4) 54 (42.0) 75 (48.4) 0.01 0.2 0.14 - 0.71
Relapse 10 (27.8) 45 (37.8) 55 (35.5) NS - (0.70 - 3.58)
ESKD 1 (2.8) 24 (20.2) 25 (16.1) 0.04 8.84 (1.15 - 67.8)
OR = odds ratio; CI = confidence interval; FSGS = focal segmental glomerulosclerosis; NS = not significant; MCD = minimal change disease; ESKD = end-stage kidney disease.
*Fourteen (48.3%) Indian and 8 (17.0%) black African children did not undergo biopsy and were presumed to have MCD.
†Membranoproliferative glomerulonephritis, membranous glomerulonephritis, mesangioproliferative glomerulonephritis.
FSGS,
61% FSGS,
73%
Presumed 
MCD, 
22%
MCD,
17%
Other,
9%
Presumed
MCD,
5%
MCD,
13%
Indian, n=65 Black, n=166
Fig. 2. Histopathology in Indian and black African children with primary nephrotic syndrome. (MCD = 
minimal change disease; FSGS = focal segmental glomerulosclerosis; other = membrano proliferative 
glomerulonephritis, membranous glomerulonephritis and mesangioproliferative glomerulonephritis.)
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24/162 (14.8%) had progressed to ESKD. Of 15 children with other 
forms of histopathology, 11/15 (73.7%) were in remission, 3 (20.0%) 
had relapsed and 1 (6.7%) had progressed to ESKD. When stratified 
by race and histopathology, at last hospital visit 9/11 (81.8%) Indian 
children with MCD were in remission and 2 (18.2%) had relapsed. 
Twenty-one black African children had MCD, 19 (90.5%) were 
in remission and 2 (9.5%) had relapsed. For Indian children with 
presumed MCD, 12/14 (85.7%) were in remission and 2 (14.3%) 
had relapsed. For black African children with presumed MCD, 7/8 
(87.5%) were in remission, none had relapsed and 1/8 (12.5%) had 
progressed to ESKD. Twenty-eight (70.0%) of 40 Indian children 
with FSGS were in remission, 11 (27.5%) had relapsed and none 
had progressed to ESKD. In 122 black African children with FSGS, 
57 (46.7%) were in remission, 42 (34.4%) had relapsed and 23 
(18.9%) had progressed to ESKD. None of the Indian children had 
histopathological findings on kidney biopsy other than FSGS or 
MCD. On comparing the frequency of FSGS in Indian and black 
African children who achieved remission, the former were more 
likely to be in remission (28 (70.0%) v. 57 (46.7%), respectively; 
p=0.01). Black African children with FSGS were more likely than 
Indian children to be in ESKD (23 (18.9%) black African v. 1 (2.5%) 
Indian; p=0.01). Fifteen black African children had other forms 
of histopathology, 11 (73.3%) were in remission, 3 (20.0%) had 
relapsed and 1 (6.7%) had progressed to ESKD (Table 3).
On comparing kidney function based on the stage of CKD 
between the initial presentation and last hospital visit, 12 (5.2%) 
children had an improvement in their kidney function, 151 (65.4%) 
remained unchanged and 68 (29.4%) progressed to higher stages 
of CKD. On comparing Indian and black African children whose 
kidney function improved, there was no significant difference 
between the two racial groups. In the group of children whose 
kidney function remained stable, 50/65 (76.9%) were Indian and 
101/166 (60.8%) were black African, with the former being more 
likely to preserve kidney function than black African children 
(OR 0.47; p=0.02; 95% CI 0.24 - 0.90). In the group of children 
whose kidney function progressed to higher stages of CKD, 11/65 
(16.9%) were Indian and 57/166 (34.3%) were black African. 
Therefore, black African children were more likely to progress to 
higher stages of CKD than Indian children (OR 2.56; p=0.01; 
95% CI 1.24 - 5-29). 
At the end of the study, there were 11 deaths; all were black African 
children. Eight children received renal replacement therapy and 
died from overwhelming sepsis. The remaining 3 children received 
palliative care; 1 died from severe sepsis due to peritonitis, whereas 
the cause of death in the remaining 2 was unknown. Seventy-three 
children were lost to follow-up; 54 (74.0%) were black African and 
19 (26.0%) Indian. Seventy-nine children were discharged to their 
base hospital or to adult care; 51 (64.6%) were black African and 28 
(35.4%) Indian. At last hospital visit 68 children were continuing care 
in the paediatric unit at IALCH; 50 (73.5%) were black African and 
18 (26.5%) Indian.
Steroid-sensitive nephrotic syndrome 
Seventy-six (32.9%) children had SSNS: 42 (55.3%) were males and 
34 (44.7%) females, with a male/female ratio of 1.2:1; 47 (61.8%) 
were black African and 29 (38.2%) Indian. There were only minor 
differences in the number of children across the three age categories, 
with 27 (35.5%) diagnosed between 1 and 3 years of age, 20 (26.3%) 
between 4 and 7 years, and 29 (38.2%) between 8 and 14 years. The 
mean (SD) age of presentation in children with SSNS was 5.8 (3.6) years. 
Sixty-five (85.5%) were from an urban setting and 11 (14.5%) from 
a rural setting. Forty-two (55.3%) children were asymptomatic 
on initial presentation and 34 (44.7%) had oedema as presenting 
symptom. Blood pressure assessment at initial visit showed that 41 
(54.0%) children were normotensive, 8 (10.5%) were prehypertensive, 
19 (25%) had stage 1 HPT and 8 (10.5%) had stage 2 HPT. There was 
a significantly high number of Indian children with SSNS presenting 
between 1 and 3 years of age compared with black African children 
(20/29 (69%) v. 7/47 (14.9%), respectively; OR 0.08; p<0.001; 
95% CI 0.03 - 0.24). Black African children presented at an older 
age: 14/47 (29.8%) black African v. 6/29 (20.7%) Indian between 
4 and 7 years old (OR 1.63; p=0.38; 95% CI 0.5 - 4.9) and 26/47 
(55.3%) black African v. 3/29 (10.3%) Indian children between 8 and 
14 years (OR 10.7; p<0.001; 95% CI 2.8 - 40.4). All Indian children 
v. 36 (76.6%) black African children were from urban settings, with 
all children from a rural background being black African (p<0.001). 
Forty-two children were asymptomatic at initial presentation and 34 
had oedema as presenting symptom, with no significant differences 
between the two racial groups. There were also no significant 
differences between the two racial groups with regard to their stage 
of HPT on initial presentation. 
Twenty-two (28.9%) children with SSNS did not undergo 
percutaneous kidney biopsy, as they had infrequent relapses and 
were classified as presumed MCD (Indian: 14/29 (48.3%); black 
African: 8/47 (17.0%)). Black African children were less likely to 
have presumed MCD than Indian children (OR 0.22; p=0.01; 
Table 3. Comparison of disease status at last hospital visit in Indian and black African children, stratified by histopathology 
Histopathology
Indian
Remission (n=49), n (%) Relapse (n=15), n (%) ESKD (n=1), n (%) Total, n
FSGS 28 (70.0) 11 (27.5) 1 (2.5) 40
MCD 9 (81.8) 2 (18.2) 0 (0.0) 11
Presumed MCD 12 (85.7) 2 (14.3) 0 (0.0) 14
Other* 0 (0.0) 0 (0.0) 0 (0.0) 0
Black
Remission (n=94), n (%) Relapse (n=47), n (%) ESKD (n=25), n (%) Total, n
FSGS 57 (46.7) 42 (34.4) 23 (18.9) 122
MCD 19 (90.5) 2 (9.5) 0 (0.0) 21
Presumed MCD 7 (87.5) 0 (0.0) 1 (12.5) 8
Other* 11 (73.3) 3 (20.0) 1 (6.7) 15
ESKD = end-stage kidney disease; FSGS = focal segmental glomerulosclerosis; MCD = minimal change disease.
*Other = membranoproliferative glomerulonephritis, membranous glomerulonephritis and mesangioproliferative glomerulonephritis.
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95% CI 0.08 - 0.60). Twenty-three (30.3%) children with SSNS who 
underwent kidney biopsy had MCD on histopathology. Twenty-
four (31.6%) children had FSGS; there was no significant difference 
between the two racial groups with regard to histopathological findings 
of MCD and FSGS. Seven (9.2%) children had histopathological 
findings other than MCD or FSGS ‒ all were black African (Table 2). 
The mean (SD) follow-up period for all children with SSNS was 
2.4 (2.2) years; Indian children were followed up for a mean (SD) 
of 3.3 (2.5) years and black African children for a mean (SD) of 
2.0 (1.9) years. At the last hospital visit, 68 (89.5%) children with 
SSNS were in remission, 7 (9.2%) had relapsed and 1 (1.3%) child 
had progressed to ESKD ‒ therefore, disease status in this last child 
could not be classified. This black African child was lost to follow-up, 
presented 6 years later in ESKD, and subsequently died from severe 
sepsis. Comparing disease status at the last hospital visit, there was no 
significant difference between the two racial groups (Table 2). 
When stratified by histopathological findings and disease status at 
last hospital visit, 23 (30.3%) children had MCD, 20 (86.9%) were in 
remission, 3 (13.0%) had relapsed and none had progressed to ESKD. 
Twenty-two (28.9%) children with SSNS who relapsed infrequently, 
did not undergo kidney biopsy and were classified as presumed MCD, 
19 (86.4%) were in remission, 2 (9.1%) had relapsed and 1 (4.5%) had 
progressed to ESKD. Twenty-four (31.6%) children with SSNS had 
FSGS, 22 (91.7%) were in remission and 2 (8.3%) had relapsed. 
All 7 (9.2%) children with SSNS who had other histopathological 
findings on kidney biopsy were in remission.
On comparing kidney function between the initial presentation and 
last hospital visit, 6 (7.9%) children with SSNS had an improvement 
in their stage of CKD, 65 (85.5%) remained stable, while 5 (6.6%) 
progressed to higher stages of CKD. There were no statistically 
significant differences between the two racial groups with regard to 
their staging of CKD between first and last hospital visit.
At the end of the study, 1 black African child with SSNS died. 
Twenty children were lost to follow-up: 13 (65.0%) were black 
African and 7 (35.0%) Indian. Thirty-two children were discharged 
to their base hospital or to adult care: 20 (62.5%) were black African 
and 12 (37.5%) Indian. At last hospital visit 23 children were 
reveiving continuing care in the paediatric unit at IALCH: 13 (56.5%) 
were black African and 10 (43.5%) Indian.
Steroid-resistant nephrotic syndrome 
A total of 155 (67.1%) children had SRNS: 79 (51.0%) were males 
and 76 (49.0%) females, with a male/female ratio of 1:1; 119 (76.8%) 
were black African and 36 (23.2%) Indian. Eighty (51.6%) children 
presented between 1 and 3 years of age, 49 (31.6%) between 4 and 7 years, 
and 26 (16.8%) between 8 and14 years, with a mean (SD) age at 
presentation of 4.3 (3.1) years. All Indian children v. 82 (68.9%) 
black African children were from an urban setting – all children 
from a rural setting were black African (p<0.001). Sixty-four (41.3%) 
child ren were asymptomatic on initial presentation and 91 (58.7%) 
had oedema as presenting symptom. Blood pressure assessment on 
initial presentation showed that 48 (31.0%) children were normo-
tensive, 17 (11.0%) prehypertensive, 54 (34.8%) had stage 1 HPT and 36 
(23.2%) stage 2 HPT. On comparison of the sexes, there were signifi-
cantly more Indian than black African males (24/36 (66.7%) v. 55/119 
(46.2%), respectively; p=0.03). There was a significantly higher 
number of Indian children presenting between 1 and 3 years than 
black African children (27/36 (75.0%) v. 53/119 (44.5%), respectively; 
OR 0.27; p=0.002; 95% CI 0.12 - 0.62). A greater number of black African 
than Indian children presented between 4 and 7 years (44/119 (37.0%) 
v. 5/36 (13.9%), respectively; OR 3.64; p=0.01; 95% CI 1.3 - 10). There 
was no significant difference between Indian and black African children 
who presented between 8 and 14 years of age. Sixty-four children were 
asymptomatic at initial presentation: 18/36 (50.0%) were Indian and 
46/119 (38.7%) black African. There was no significant differences 
between the two racial groups regarding symptoms at initial presenta-
tion. Indian children were more likely to be normotensive than black 
African children (18/36 (50.0%) v. 30/119 (25.2%), respectively; OR 0.34; 
p=0.006; 95% CI 0.2 - 0.6). There were no significant differences at 
initial presentation when comparing prehypertension or stage 1 HPT 
between Indian and black African children. Although Indian children 
were less likely to have stage 2 HPT than black African children, this 
did not reach statistical significance.
All children with SRNS underwent percutaneous kidney biopsy, 9 
(5.8%) had MCD, 138 (89.0%) had FSGS and in 8 (5.2%) there were 
other histopathological findings (Table 2). Indian children with SRNS 
were significantly more likely to have MCD than black African children 
(5/36 (13.9%) v. 4/119 (3.4%), respectively; OR 0.22; p=0.03; 
95% CI 0.05 - 0.85). Thirty-one of 36 (86.1%) Indian and 107/119 
(89.9%) black African children had FSGS, with no significant difference 
between the two racial groups. All 8 children with histopathological 
findings other than MCD or FSGS were black African: 1 (12.5%) had 
membranoproliferative glomerulonephritis and 7 (87.5%) idiopathic 
membranous glomerulonephritis (Table 2).
The mean (SD) follow-up period for all children with SRNS was 
3.3 (2.6) years; Indian children were followed up for 3.6 (3.0) years 
and black African children for 3.1 (2.4) years. At last hospital visit, 
75 (48.4%) children with SRNS were in remission, 55 (35.5%) had 
relapsed and 25 (16.1%) were in ESKD; therefore, disease status could 
not be classified in the latter group. On comparison of disease status 
at last hospital visit between the two racial groups, 25/36 (69.4%) 
Indian v. 50/119 (42.0%) black African children were in remission, 
with significantly more Indian children being in remission than black 
African children (OR 0.32; p=0.01; 95% CI 0.14 - 0.71). With regard to 
children who had relapsed, there was no significant difference between 
the two racial groups. One of 36 (2.8%) Indian and 24/119 (20.2%) 
black African children progressed to ESKD. Black African children 
were significantly more likely to progress to ESKD than Indian children 
(OR 8.84; p=0.04; 95% CI 1.15 - 67.8).
When stratified by histopathological findings and disease status at last 
hospital visit, of 9 (5.8%) children with MCD and SRNS, 8/9 (88.9%) 
were in remission, 1 (11.1%) had relapsed and none had progressed to 
ESKD. One hundred and thirty-eight (89.0%) children with SRNS had 
FSGS, 63 (45.7%) were in remission, 51 (37.0%) had relapsed and 24 
(17.4%) had progressed to ESKD. Eight (5.2%) children had other forms 
of histopathological findings, 4 (50.0%) were in remission, 3 (37.5%) had 
relapsed and 1 (12.5%) had progressed to ESKD.
On comparing staging of CKD between the initial presentation and 
last hospital visit, 6 (3.9%) children with SRNS had an improvement 
in their CKD staging, 86 (55.5%) had no change, and 63 (40.6%) had 
progressed to higher stages of CKD. Ten of 36 (27.8%) Indian children 
and 53/119 (44.5%) black African children had progressed to a higher 
stage of CKD. Black African children were more likely to progress to 
higher stages of CKD than Indian children, although this did not reach 
statistical significance.
At the conclusion of the study, there were 10 deaths in children with 
SRNS ‒ all were black African. Fifty-three children were lost to follow-
up: 41 (77.4%) were black African and 12 (22.6%) Indian. Forty-seven 
children were discharged to their base hospital or adult care: 31 (66.0%) 
were black African and 16 (34.0%) Indian. Forty-five children at last 
hospital visit received continuing care in the paediatric unit at IALCH: 
37 (82.2%) were black African and 8 (17.8%) Indian.
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Discussion 
To date, in the new millennium there have been only two major 
reports focusing on the spectrum of primary NS in SA children – one 
was confined to biopsy-proven MCD.[19,20] The most recent studies 
globally and in Africa focused on NS in general, SSNS (presumed 
MCD) or SRNS.[19-27] In this study, we focused on children with 
primary NS and report on the histopathological spectrum, response 
to steroids and outcome of these children seen at a central hospital in 
KwaZulu-Natal. We highlight the differences in the pattern of disease 
in black African and Indian children – two dominant racial groups 
seen in our hospital. There have been no other reports of primary 
NS in children from this region, except from Bhimma et al.,[14] who 
in 1997 focused on NS in general. We have excluded congenital and 
secondary forms of NS, as these will be reported separately.
The main findings in our study can be summarised as follows: 
there was a predominance of black African children, mainly from an 
urban setting, with just fewer than half being asymptomatic at the 
time of their first presentation to hospital. The clinical presentation 
at the initial visit, however, was similar in both racial groups. Overall, 
there were slightly more males than females; this difference was 
accentuated in Indian children, but there was a preponderance of 
black African female children, especially in the group with SRNS. 
The mean age of presentation was 4.8 years, with a mean follow-up 
of 3.0 years. On initial presentation, HPT was present in about half of 
the children, with black African children being two times more likely 
to have stage 2 HPT than Indian children. Just more than two-thirds 
of children had SRNS – black African children being two times more 
likely to have the condition than Indian children. With regard to 
SSNS, Indian children presented at an earlier age than black African 
children. With regard to SRNS, black African children presented at 
a significantly older age than Indian children. Indian children were 
more likely to relapse infrequently. Both racial groups with SSNS 
showed high rates of remission, with no statistically significant 
differences between the groups. Also, in children with SSNS, there 
were no significant differences in the histopathological pattern of 
disease in both racial groups. However, in children with SRNS, FSGS 
was more prevalent in black African children than Indian children; the 
former were less likely to achieve remission and more likely to progress 
to higher stages of CKD. All except 1 child who progressed to ESKD 
were black African, the majority having FSGS on histopathology.
In a previous general report on NS by Bhimma et al.,[14] Indian 
children comprised 48.2% of the study population; in our study it 
was 28.1%. Black African children now comprised 71.9% compared 
with 48.2% in the previous general report on NS from this region, 
with a very low representation of white and mixed-race groups. The 
preponderance of black African children in our study reflects not 
only the population demographics of the various racial groups in 
KwaZulu-Natal, but is also a reflection of the utility of public health 
services in the country in general. Other racial groups with a better 
socioeconomic background use private healthcare, which provides 
better facilities, turnaround times and an appropriate level of care, as 
there are paediatric nephrologists in private practice.
Whereas most SA studies, in keeping with those from the developed 
world, report a higher frequency of males than females with primary 
NS, our study showed more female than male black African children. 
This difference was most pronounced in black African children 
with SRNS.[14,19,21,28] Black African children also presented at an older 
age than those reported in other studies, both locally and inter -
nationally.[19,21-27] Furthermore, the mean (SD) age of presentation was 
6.2 (3.4) years, which is slightly higher than that previously reported 
in SA children,[14,19] probably due to late diagnosis in our study group. 
Just fewer than half of the children in our study were asymptomatic at 
the time of initial presentation. While the majority with primary NS 
presented stereotypically with varying degrees of oedema, the large 
number of children who were asymptomatic at the time of initial 
presentation is probably due to our referral pattern. All children 
presenting to the central hospital are initially treated at a base 
hospital. Oedema in children would have been controlled prior to 
referral to the central hospital, the majority being referred for kidney 
biopsy and intensive treatment as they were SR. 
The high frequency of HPT in the current study, particularly in black 
African children with SRNS, is in contrast to the much lower incidence 
reported by Bhimma et al.[14] This low incidence of HPT in previous 
studies may be due to resource limitations, with fewer children having 
blood pressure accurately measured and HPT documented. It could 
also possibly reflect the change in racial demographics – black African 
children being the predominant racial group in our study population, 
the majority having FSGS with SRNS and therefore being more likely to 
have HPT.[14] The high frequency of HPT, particularly in black African 
children with primary NS, is supported by a study from an academic 
hospital in Johannesburg, SA.[19]
One of the most striking differences in our study compared 
with previous reports from this region was the change in the 
histopathological pattern of disease and response to steroids. The 
burden of SRNS increased substantially from 30.5% previously 
reported by Bhimma et al.[14] to 67.1% in the current study. This 
increased burden of SRNS was mirrored by an increase in children 
with FSGS, with a concomitant decline in the incidence of MCD 
from 30.8% to 13.9%.[14] From being a marginal therapeutic issue 
in our centre, FSGS has now become the single most common 
histopathological finding in children with primary NS and a 
management problem. In our study, FSGS was diagnosed in 70.1% of 
children with primary NS, which is much higher than the previously 
reported figures of 3.7% (1976), 3.9% (1981) and 25% (1997) from 
other centres in SA, including our centre.[4,5,14] This increase in 
the incidence of FSGS, albeit exceedingly high, is in line with the 
increasing incidence of FSGS reported from many other paediatric 
nephrology units, where it accounts for 10 - 20% of children with 
primary NS.[29-31] A review of FSGS supports the view that there has 
been an authentic increase in the disease, as documented in other 
reports from geographically distinct regions.[32-34] The same process 
may be occurring in SA. However, the increase may also be due to 
better pathological identification of biopsy tissue, more biopsies 
being performed or improved access to health services in the new 
millennium. The low incidence of MCD in our study (13.9%) may 
not be a true reflection of the incidence of this disease in the general 
population. It may reflect selection bias, with only difficult-to-treat 
NS being referred to the central hospital, as well as centre-specific 
indications for biopsy, where only children with frequently relapsing, 
steroid-dependent or SRNS are biopsied. Similar to previous findings 
from this region, black African children were more likely to be SR 
than Indian children.[4,5,14]
An unusual finding in our present study was the larger number 
of black African children being steroid responsive, in keeping with 
reports from other regions in SA.[8,9] Of the 76 children with SSNS, 
61.8% were black African compared with a previous study from this 
region, where only 14.4% of black African children had SSNS; 31.9% 
had FSGS compared with SSNS children from other races in the 
previous study.[14]
Only 1 child with presumed MCD, who may have been missed as 
having FSGS, as he was initially SS and lost to follow-up, presented 6 
years later with ESKD. All except 2 children who progressed to ESKD 
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had FSGS, making it the most common histopathological form of NS 
to progress to ESKD, which is in keeping with the literature.[14,35,36] All 
except 1 child who progressed to ESKD were black African children, 
highlighting the more aggressive progression of kidney disease in 
children of African descent.[9,36,37] Indian children were more likely 
to preserve kidney function, while black African children were more 
likely to progress to higher stages of CKD.
Only about two-thirds of children with primary NS who progressed 
to ESKD qualified for some form of renal replacement therapy. 
Although this is an improvement from our previous experience 
of <10% of children having access to such therapy (R Bhimma – 
personal communication, 2019), it is probably a reflection of the 
plight of our children, with poor socioeconomic factors being one of 
the major determinants of eligibility for renal replacement therapy. 
The high cost of this therapy, lack of trained staff, late referral 
of children with comorbidities and lack of kidney donors due to 
religious beliefs make it increasingly difficult for all children with 
ESKD to be part of a programme for renal replacement therapy. 
In our centre, only children eligible for kidney transplantation are 
entered into a chronic dialysis programme. 
Study limitations
There are several limitations to this study. This was a retrospective 
single-centre study of children with primary NS. Seven children with 
incomplete records and children >14 years of age were excluded from 
the analysis. There may have been children with primary NS not 
referred to the central hospital, lost to follow-up or who died before a 
referral from the base hospital. We did not fully evaluate the response 
to the different forms of therapy other than steroids. There is a 
strong selection bias, as only children with difficult-to-treat NS are 
referred to the central hospital. There is a dearth of white or mixed-
race children who are not represented in the analysis owing to the 
small numbers seen in our centre. We were not able to document the 
complications of the disease accurately, except death, due to coding 
irregularities in the computer system.
Conclusions
Our study comprises one of the largest cohorts of children with 
primary NS from a single centre in KwaZulu-Natal and shows 
a rising incidence in FSGS, with the majority having SRNS, 
particularly black African children. This highlights the need for 
alternative efficacious therapy in the management of the disease. 
We have documented a higher percentage of black African children 
with both MCD and FSGS on histopathology who are SS, in 
keeping with reports from other regions of SA. Renal replacement 
therapy is currently more readily available, but there are still major 
challenges for the inclusion of all children into a chronic dialysis 
and transplant programme. 
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